Foghorn Therapeutics, Inc. (FHTX)
4.16
+0.02
(+0.48%)
USD |
NASDAQ |
Sep 21, 16:00
4.30
+0.14
(+3.37%)
After-Hours: 20:00
Foghorn Therapeutics Market Cap : 244.25M for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 243.08M |
| September 17, 2026 | 246.60M |
| September 16, 2026 | 244.84M |
| September 15, 2026 | 241.90M |
| September 14, 2026 | 255.99M |
| September 11, 2026 | 259.52M |
| September 10, 2026 | 263.63M |
| September 09, 2026 | 274.20M |
| September 08, 2026 | 283.59M |
| September 04, 2026 | 288.87M |
| September 03, 2026 | 285.94M |
| September 02, 2026 | 303.55M |
| September 01, 2026 | 334.08M |
| August 31, 2026 | 337.02M |
| August 28, 2026 | 352.29M |
| August 27, 2026 | 365.20M |
| August 26, 2026 | 392.80M |
| August 25, 2026 | 402.19M |
| August 24, 2026 | 403.37M |
| August 21, 2026 | 415.11M |
| August 20, 2026 | 411.59M |
| August 19, 2026 | 414.52M |
| August 18, 2026 | 396.32M |
| August 17, 2026 | 395.73M |
| August 14, 2026 | 367.55M |
| Date | Value |
|---|---|
| August 13, 2026 | 381.06M |
| August 12, 2026 | 389.86M |
| August 11, 2026 | 386.93M |
| August 10, 2026 | 366.38M |
| August 07, 2026 | 356.40M |
| August 06, 2026 | 327.04M |
| August 05, 2026 | 286.53M |
| August 04, 2026 | 285.35M |
| August 03, 2026 | 270.66M |
| July 31, 2026 | 265.96M |
| July 30, 2026 | 278.29M |
| July 29, 2026 | 278.29M |
| July 28, 2026 | 301.18M |
| July 27, 2026 | 305.29M |
| July 24, 2026 | 284.75M |
| July 23, 2026 | 297.66M |
| July 22, 2026 | 305.88M |
| July 21, 2026 | 302.95M |
| July 20, 2026 | 304.71M |
| July 17, 2026 | 304.71M |
| July 16, 2026 | 297.66M |
| July 15, 2026 | 319.97M |
| July 14, 2026 | 315.86M |
| July 13, 2026 | 319.39M |
| July 10, 2026 | 349.33M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Prime Medicine, Inc. | 576.55M |
| Arrowhead Pharmaceuticals, Inc. | 9.710B |
| Oncolytics Biotech, Inc. | 95.71M |
| Sangamo Therapeutics, Inc. | 60.03M |
| Sarepta Therapeutics, Inc. | 2.126B |
Market Cap Related Metrics
| PS Ratio | 7.356 |
| Price | 4.16 |
| Earnings Yield | -24.55% |